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Abstract
Background: Modern broiler chickens exhibit very rapid growth and high feed efficiency compared to unselected
chicken breeds. The improved production efficiency in modern broiler chickens was achieved by the intensive
genetic selection for meat production. This study was designed to investigate the genetic alterations accumulated
in modern broiler breeder lines during selective breeding conducted over several decades.
Methods: To identify genes important in determining muscle growth and feed efficiency in broilers, RNA sequencing
(RNAseq) was conducted with breast muscle in modern pedigree male (PeM) broilers (n = 6 per group), and with an
unselected foundation broiler line (Barred Plymouth Rock; BPR). The RNAseq analysis was carried out using Ilumina Hiseq
(2 x 100 bp paired end read) and raw reads were assembled with the galgal4 reference chicken genome. With
normalized RPM values, genes showing >10 average read counts were chosen and genes showing <0.05 p-value and
>1.3 fold change were considered as differentially expressed (DE) between PeM and BPR. DE genes were subjected to
Ingenuity Pathway Analysis (IPA) for bioinformatic functional interpretation.
Results: The results indicate that 2,464 DE genes were identified in the comparison between PeM and BPR. Interestingly,
the expression of genes encoding mitochondrial proteins in chicken are significantly biased towards the BPR group,
suggesting a lowered mitochondrial content in PeM chicken muscles compared to BPR chicken. This result is
inconsistent with more slow muscle fibers bearing a lower mitochondrial content in the PeM. The molecular, cellular and
physiological functions of DE genes in the comparison between PeM and BPR include organismal injury, carbohydrate
metabolism, cell growth/proliferation, and skeletal muscle system development, indicating that cellular mechanisms in
modern broiler lines are tightly associated with rapid growth and differential muscle fiber contents compared to the
unselected BPR line. Particularly, PDGF (platelet derived growth factor) signaling and NFE2L2 (nuclear factor, erythroid
2-like 2; also known as NRF2) mediated oxidative stress response pathways appear to be activated in modern broiler
compared to the foundational BPR line. Upstream and network analyses revealed that the MSTN (myostatin) –FST
(follistatin) interactions and inhibition of AR (androgen receptor) were predicted to be effective regulatory factors for DE
genes in modern broiler line. PRKAG3 (protein kinase, AMP-activated, gamma 3 non-catalytic subunit) and LIPE (lipase E)
are predicted as core regulatory factors for myogenic development, nutrient and lipid metabolism.
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Conclusion: The highly upregulated genes in PeM may represent phenotypes of subclinical myopathy commonly
observed in the commercial broiler breast tissue, that can lead to muscle hardening, named as woody breast. By
investigating global gene expression in a highly selected pedigree broiler line and a foundational breed (Barred
Plymouth Rock), the results provide insight into cellular mechanisms that regulate muscle growth, fiber composition and
feed efficiency.
Background
Production efficiency in animal agriculture continues to
be of vital importance to meet the protein nutrition
needs of an ever increasing global human population.
Genetically selected modern broiler chickens acquired
highly improved production efficiency through rapid
growth and high feed efficiency compared to unselected
chicken breeds. Thus, understanding of mechanisms
regulating rapid muscle growth and high feed efficiency
may play an increasingly important role in developing
more efficient, and therefore sustainable, animal produc-
tion systems [1].
A global gene expression study using cDNA micro-
array assay was conducted on breast muscle phenotyped
by high and low production efficiency in male pedigree
broiler breeder chickens [2–4]. Additional global gene
expression studies have been performed with breast
muscle tissue using RNAseq in commercial broilers [5]
and duodenal tissue using RNAseq in broilers selected
for low and high residual feed intake (RFI) [6]. Several
global expression studies showed that production efficiency
may be associated with various cellular mechanisms includ-
ing mitochondrial oxidative stress, inflammatory response,
protein degradation, stress responses, growth hormone
signaling, cell cycle, apoptosis and fatty acid transportation.
A recent study on the transcriptome analyses of breast
muscles in modern pedigree broiler chicken and legacy
chicken lines reported that the transcriptional profile of
differentially enriched genes on day 6 and day 21 in modern
broiler muscles includes genes for enhanced myogenic
growth and differentiation [7].
The Barred Plymouth Rock (BPR) chicken, with its
characteristic pattern of alternating white and black bars
of feather pigmentation were developed by crosses
involving the Black Java, Black Cochin, and Dominique
breeds in America during the mid-19th century [8] and
is a foundational or heritage breed of the modern
commercial broilers. The BPR breed, originally devel-
oped for the dual purposes of both meat and egg
production, has much slower growth rate (589 g empty
body weight at 42 days) compared to commercial
broilers (2276 g at 42 days) [9].
With distinct differences in growth characteristics, the
objective of the present study was to conduct global
gene expression analyses on breast muscle tissue
obtained from modern pedigree male (PeM) broilers
(rapid growth and muscle development) compared with
the foundational BPR chickens (slow growth and lower
efficiency) [9]. Recent popular RNA-sequencing method
using massively parallel nucleotide sequencing tech-
niques were used for the comparison of global gene
expression in this study. From this comparison, DE genes
showing greater differences between the two groups may
provide more definitive insights into cellular regulatory
mechanisms in muscle growth and feed efficiency.
Methods
Ethics Statement
The present study was conducted in accordance with
the recommendations in the guide for the care and use
of laboratory animals of the National Institutes of
Health. All procedures for animal care complied with
the University of Arkansas Institutional Animal Care
and Use Committee (IACUC): Protocol #14012.
Animals, breast muscle tissue and RNA extraction
Breast muscle tissue analyzed in this study were obtained
from immature (≤8 weeks old) pedigree broiler males
(PeM) and BPR. The PeM samples had been obtained
previously [2] and from an inbred male line highly selected
for growth and feed efficiency [10]. Briefly, immature PeM
and BPR chickens (<8 weeks old, n = 6 per breed) were
killed by an overdose of sodium pentobarbital (i.v.) and
breast muscle tissue obtained and flash frozen in liquid
nitrogen. RNA was extracted from breast muscle using
TRIzol reagent (Invitrogen Life Technologies, Thermo-
Fisher Scientific, Carlsbad, CA) following the manufac-
turer’s instructions. After the first RNA extraction, the
RNA samples were treated with DNase I (New England
Biolabs Inc., Ipswich, MA) and extracted again with
TRIzol reagent. The RNA quality was then assessed by
Agilent 2200 TapeStation instrument (Santa Clara, CA).
The RNA samples were used for RNA sequencing (RNAseq)
analysis.
RNAseq and data analysis
RNAseq library preparation for individual samples with
barcoding and Illumina sequencing were performed by
the Research Technology Support Facility at Michigan
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State University (East Lansing, MI). Illumina HiSeq
system 2x100 bp paired end read technology was used
for RNAseq. The RNA sequence FASTA files were
mapped to the chicken genome (galgal4) retrieved from
Ensembl using CLC Genomics Workbench software




RNA-Seq_analysis_part_I.pdf ) and the RNAseq analyt-
ical pipeline recommended in [11]. Briefly, raw reads
were processed by reads’ quality control and adapter
trimming with default setting. Filtered reads were
subjected to reference based-RNAseq pipeline of CLC
software with default settings. The EMBL annotation files of
reference chicken genome were downloaded from Ensembl
(ftp://ftp.ensembl.org/pub/release-87/embl/gallus_gallus/)
and tracks for sequence and genes were generated with
track conversion. The parameters of initial RNAseq map-
ping are as followings: Use reference genome annotated
with genes and transcripts; Eukaryote origin; Map to gene
region only; mapping options with 2 mismatch costs, 3
insertion costs, 3 deletion costs, 0.7 length fraction, 0.8
similarity fraction, both strand specific, 10 maximum
number of hits for a read; total counts for expression value.
Total mapped counts were transformed to log2 values of the
number of reads per million (RPM) to stabilize the variance
and then a further quantile normalization was performed
[11]. Normalized values were subjected to further statistical
analyses performed by JMP Genomics 6 (SAS Institute Inc.,
Cary, NC). Genes with less than 10 average raw read counts
in both comparison groups were removed and not
considered for further analyses. The t-statistics was used to
compare between PeM and BPR. Genes showing >1.3 fold
differences and <0.05 p-value in the comparison between
PeM and BPR were considered differentially expressed (DE)
genes. The p-value correction (FDR calculation) by multiple
tests was not applied in this study since we used a less
stringent approach on a gene by gene basis, and this allowed
us to import much more informative lists and assess the
genome-wide data using various alternative approaches,
such as the hyper-geometric stats used by functional enrich-
ments for pathway analyses, the co-expression patterns in
the hierarchical heatmaps, and the binomial distributions in
the mitoproteome plot [12, 13].
Mitoproteome analysis
The complete human mitoproteome was downloaded
from http://mitominer.mrc-mbu.cam.ac.uk/release-3.1/
begin.do generating a list of 1,046 nuclear and mito-
chondrial genes encoding mitochondrial proteins. Pro-
tein names were converted to gene names and 699 genes
matched the chicken RNAseq data in this study. The
expression of mitoproteome genes was then plotted in
MA format, and all those with higher values in the PeM
group were color coded red and those with lower values
in the PeM color coded blue. The skew in distribution
away from the null expectation of 50:50 was quantified
by binomial statistics. This approach formalizes the
extent to which the mitoproteome data is biased to one
or the other of the two groups.
Hierarchical clustering analysis
The genes with greatest DE (20 up- and 20 down-
regulated) between PeM and BPR were subjected to
hierarchical cluster analysis using the JMP Genomics
program. We imported the matrix with as many col-
umns as birds (12) and as many rows as genes (40),
where each cell contains the log2 transformed fold
change value for that gene and individual into JMP
Genomics program, normalizing on rows. We applied
hierarchical clustering on both rows and columns and
exported the resulting dendrogram as an image file.
Pathway analyses
Ingenuity Pathway Analysis (IPA; Qiagen, Valencia, CA;
http://www.ingenuity.com) software was used for func-
tional annotation, canonical pathway analysis, upstream
analysis and network discovery. Because IPA is based on
the bioinformatics in humans, functionalities for differ-
entially expressed genes in our chicken datasets are
based primarily on mammalian biological mechanisms.
As the investment in biomedical research biases the
functional annotations towards human disease, we have
attempted to draw plausible conclusions based on avian
based literature.
Quantitative RT-PCR
One microgram of total RNA was obtained from 6 muscle
samples each for PeM and BPR for general validation of
the RNAseq results and for specific confirmation of the
top 10 genes, respectively. RNA was converted into cDNA
with qScript™ cDNA SuperMix (Quanta Biosciences,
Gaithersburg, MD) following the manufacturer’s instruc-
tions. The cDNA samples were diluted in a 1:10 ratio and
a portion (2 μL) of the cDNA was subjected to a real-time
quantitative PCR (qPCR) reaction using an ABI prism
7500HT system (ThermoFisher Scientific, Waltham, MA)
with PowerUp™ SYBR® Green Master Mix (ThermoFisher
Scientific, Waltham, MA). The specific oligonucleotide
primers were designed by the PRIMER3 program (http://
frodo.wi.mit.edu) and the list of primers were listed in
Additional file 1. The conditions of real-time qPCR ampli-
fication were 1 cycle at 95 °C for 2 min, 40 cycles at 95 °C
for 30 s, 65 °C for 30 s. The chicken glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) gene was used as the
internal control. Dissociation curves were performed at
the end of amplification for validating data quality. All
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qPCR reactions were performed 3 times and the values of
average cycle threshold (Ct) were determined for each
sample, and 2−ΔΔCt values for the comparison of PeM and




Twelve RNAseq libraries were constructed using RNA
samples of breast muscles from 6 chickens each for PeM
and BPR and sequenced with 2x 100 bp paired end reads
on 4 lanes. Totally ~800 million 100 bp sequence reads
were obtained with an average of ~67 million reads per
sample and ~80% of sequence reads were mapped to the
chicken reference genome (galgal4). After quantile
normalization with log2 transformation of the number of
reads per million (RPM) and filtering out very low ex-
pression genes (raw read counts <10), 9,263 genes
remained and the MA plot showed that up- and down-
regulated genes were evenly distributed in the compari-
son between PeM and BPR (Fig. 1a). Finally, 2,464 DE
genes showing <0.05 p-value and >1.3 fold change were
identified in the comparison between PeM and BPR
(Additional File 2). To validate RNAseq results, a subset
of 20 genes selected from the DE list were subjected to
qPCR. These were genes associated with muscle struc-
tures [slow twitch subunits (MYH15, TPM3, MYOZ2,
TNNI1, MYBPC1), slow muscle associated proteins
A
B
Fig. 1 MA plots and number of DE genes. (a) MA plot for the comparison of PeM and BPR. (b) MA plot for mitoproteome genes of PeM vs. BPR.
In (a) and (b), y and x axis represent the log ratio of differential expression and the average expression, respectively, for each gene in groups of
PeM and BPR
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(MB, CA3), muscle fat content (PLN, FABP4), muscle
growth/differentiation (MSTN)], mitochondrial biogen-
esis and proteins (PPARGC1A, PPARGC1B, CKMT1A,
NOXO1), and five out of the top 10 downregulated
genes (IL23R, GPM6A, PPDPF, ACE, CD9). Results indi-
cated that expression levels for 16 genes out of 20 tested
were well-matched between RNAseq and qPCR analyses
in terms of the direction and magnitude of change
(Table 1). Four genes were not matched between
RNAseq and qPCR for reasons that are not clear to us,
but one possibility relates to the fact that the two
methods use quite different normalization approaches.
Those transcripts where the two methods make similar
DE predictions can be considered the most robust of
our reported data. Additionally, hierarchical clustering
showed clear discrimination the 12 birds into the correct
group of origin (Fig. 2).
Of the 699 genes that were detected that encode
proteins localized to the mitochondrion, 194 and 447
were numerically higher and lower, respectively, in
PeM compared to BPR, while 58 genes were not
changed (Fig. 1b). This is a very significant skew
(binomial P value < 0.000001) implying the PeM birds
have a lowered mitochondrial content. Recently, a breast
muscle transcriptomic analyses using RNAseq method
was reported on the comparison between the broiler pedi-
gree Ross and a legacy Illinois chicken line [7]. When raw
sequencing data, which is available on Gene Expression
Omnibus (GEO), were reanalyzed for gene expression, the
608 genes encoding proteins localized to the mitochon-
drion were differentially expressed as 251 and 357 were
up- and downregulated, respectively, in the 21 day old
Ross chickens compared to Illinois chickens (data not
shown; Seo et al., manuscript in preparation). Similar find-
ings of these two independent studies showing a lower
number of upregulated genes encoding mitochondrial
proteins in modern broiler compared to unselected
chicken breeds may strongly support reduced numbers of
mitochondrial content in modern breeds selected for
growth and feed efficiency.
This mitochondrial content finding is in line with the
economic physiological design argument proposed by
Hudson [14] in the context of production animal feed
efficiency. This argument proposes that an economically
designed feed converter should have enough, but not too
much, fuel burning capacity. This is because spare
Table 1 Comparison of fold changes between RNAseq and
qPCR
PeM vs. BPR





















* Values denote linear fold changes
** Inconsistent fold change between RNAseq and qPCR were italicized
Fig. 2 A hierarchically clustered heatmap showing the expression
patterns of the 40 most extreme DE mRNA. Red and blue represent
up- and downregulated expression in PeM, respectively. Color
density indicating levels of fold change was displayed
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capacity bears costs of construction (mitochondrial bio-
genesis), maintenance (trans-membrane proton gradient)
and load (space that could be used for other organelles)
that should be avoided if they are unnecessary.
Hierarchical clustering on extreme DE
The top 20 up- and 20 downregulated genes were sub-
jected to hierarchical clustering analysis (Fig. 2). The re-
sults clearly discriminate the 12 birds into the correct
group of origin. Functional groups contained in the 20
upregulated genes in PeM include cytoskeleton and
muscle contraction [LMOD2 (leiomodin 2, cardiac), CA3
(carbonic anhydrase III), MUSTN1 (musculoskeletal, em-
bryonic nuclear protein 1), TNNT2 (troponin T type 2,
cardiac), MYBPC1 (myosin binding protein C, slow type),
MB (myoglobin), MYH15 (myosin heavy chain 15)], extra-
cellular matrix [or secreting proteins; TNC (tenascin C),
ANGPTL5 (angiopoietin-like 5), NOV (nephroblastoma
overexpressed), IGJ (joining chain of multimeric IgA and
IgM)], transporter [PLN (phospholamban), MB], protease
[PCSK1 (proprotein convertase subtilisin/kexin type 1)],
and ion channel [SCN5A (sodium channel, voltage gated,
type V alpha subunit)]. Functional groups contained in the
20 downregulated genes include transcription factors
[FHL2 (four and a half LIM domains 2), KLF9 (Kruppel-
like factor 9)], calcium signaling [PROCA1 (protein inter-
acting with cyclin A1), GPM6A (glycoprotein M6A)],
synthetic enzymes [GART (phosphoribosylglycinamide
formyltransferase), CGT (UDP glycosyltransferase 8),
RHOF (ras homolog family member F), GSTA3 (glutathi-
one S-transferase alpha 3)], protein ubiquitination
[KLHL38 (kelch-like family member 38)], membrane
bound [SLC38A4 (solute carrier family 38, member 4),
CD9 (CD9 molecule), ACE (angiotensin I converting en-
zyme), GPM6A, IL23R (interleukin 23 receptor)], and se-
creting protein [DKK2 (dickkopf WNT signaling pathway
inhibitor 2), KL (klotho)]. More details on the function of
a narrower list for the 10 most DE genes are described
below.
The 10 most DE genes
The full name of the 10 most DE genes between PeM
and BPR muscle and their functional characteristics are
shown in Tables 2 and 3. Interestingly, highly upregu-
lated genes in PeM muscle are closely associated with
expression of gene and phenotypes of subclinical myop-
athy commonly observed in the commercial broiler
breast tissue, as discussed below. Five of the 10 most up-
regulated genes (LMOD2, CA3, MUSTN1, TNNT2, and
MYBPC1) in PeM are mainly expressed in skeletal or
cardiac muscles (Tables 2 and 3), particularly in slow
twitch fibers (type 1), except for MUSTN1 which is not
expressed in slow twitch fibers. This observation indi-
cates that breast muscle in PeM chickens could have
higher slow fiber composition compared to BPR muscle.
When considering the mitoproteome and mitochondrial
contents discussed earlier, the possible higher slow fiber
composition in PeM is counter to the lowered gene ex-
pression for mitoproteome, which are typically associ-
ated with fast twitch muscle fibers. Generally, slow-
twitch or oxidative fibers have high mitochondrial
content, slow contraction rates, increased reliance on
oxidative phosphorylation (OXPHOS), high resistance to
fatigue, and high representation in postural muscles. In
contrast, fast-twitch or glycolytic fibers have lower mito-
chondrial content, rapid contractions, decreased reliance
on OXPHOS, low resistance to fatigue, and high repre-
sentation in muscle groups used for directional move-
ment [15]. In general, we know that chickens have a
white breast muscle with a very high preponderance of
fast twitch glycolytic fibers bearing a low mitochondrial
Table 2 The 10 most differentially expressed genes in breast
muscle tissue modern PeM broiler males compared to
progenitor BPR broilers
FC p-value Symbol Entrez gene name
Up-regulation
48.16 6.4E-05 PLIN1 perilipin 1
32.22 9.2E-07 LMOD2 leiomodin 2 (cardiac)
30.27 7.9E-04 CA3 carbonic anhydrase III
26.72 1.7E-07 MUSTN1 musculoskeletal, embryonic nuclear
protein 1
20.96 1.2E-05 TNNT2 troponin T type 2 (cardiac)
19.97 4.8E-06 HSPB7 heat shock 27 kDa protein family,
member 7 (cardiovascular)
18.12 1.0E-06 NOXO1 NADPH oxidase organizer 1
13.83 8.1E-05 PLN phospholamban
12.99 2.8E-05 PCSK1 proprotein convertase subtilisin/kexin
type 1
12.55 9.2E-04 MYBPC1 myosin binding protein C, slow type
Down-regulation
−13.36 9.6E-07 IL23R interleukin 23 receptor
−11.39 4.2E-05 GPM6A glycoprotein M6A
−8.81 1.5E-02 KL klotho
−7.72 7.8E-05 AGMAT agmatine ureohydrolase (agmatinase)
−7.72 1.1E-04 DKK2 dickkopf WNT signaling pathway
inhibitor 2
−7.21 1.4E-03 GABRD gamma-aminobutyric acid (GABA) A
receptor, delta
−6.54 4.5E-03 FGB fibrinogen beta chain
−6.49 1.1E-06 PPDPF pancreatic progenitor cell differentiation
and proliferation factor
−6.02 4.5E-06 ACE angiotensin I converting enzyme
−5.93 3.6E-05 CD9 CD9 molecule
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content (e.g. [16]). Based on the DE genes encoding
mitochondrial proteins (Fig. 1b), modern PeM breast
muscles may contain an even higher content of fast
twitch fibers compared to BPR muscle. However, the
most upregulated genes showed the possibility of muscle
composition, that contain higher gene expression for the
slow muscle fiber composition in modern PeM com-
pared to BPR. This indicates that chicken breast muscle
mostly consists of fast fibers, more rapidly growing mod-
ern PeM broiler muscle contains increased slow fiber
compositions, and the increased mass of slow fibers may
be regulated independently of mitochondrial content
and function. It also suggests that the mitochondria in
avian muscle may function to regulate muscle mass
growth by modulating oxidative stress, but may not
regulate fiber composition. These results may represent
a fundamentally new finding about muscle physiology
in birds. In an earlier report by Mutryn et al. [17],
wooden breast myopathy muscle (which in commercial
broilers showed a dramatic upregulation of TNNI1, MB,




PLIN1 • Is a member of the PLIN family, which has a specific role
in regulating lipolysis
• Expresses only in adipose tissue, not in skeletal muscle in
mammals [18]
• Limits the activity of the rate-limiting lipase, adipose
triglyceride (ATGL) in a basal state [67]
• Induces hormone-sensitive lipases recruitment by its
phosphorylation [68]
LMOD2 • Is a member of tropomodulin family which is an actin
filament elongation protein
• Is restricted to skeletal and cardiac muscle [69]
• Functions to maintain thin filament lengths in the
mature heart [70]
CA3 • Is a class of metalloenzymes that catalyze the reversible
hydration of CO2
• Expresses at high levels in skeletal muscle and much
lower levels in cardiac and smooth muscle [71]
• Functions to generate both bicarbonate and hydrogen
ions for maintenance of pH homeostasis
MUSTN1 • Expresses predominantly in the skeletal muscles and
tendons in chicken and mammals [72]
• Knock-down leads to the inhibition of myogenic fusion
and differentiation [73]
• Plays a role in muscle development
TNNT2 • Is a tropomyosin binding subunit of the troponin
complex, which is located on the thin filament of
striated muscles
• Regulates muscle contraction in response to alterations
in intracellular Ca2+ concentration [74]
HSPB7 • Is widely expressed throughout the body [75]
• Prevent polyQ-induced toxicity in mammalian cells by
suppressing aggregation and does not induce
autophagy [76]
NOXO1 • Regulates NOX1 positively [77]
• Functions in superoxide production [78]
PLN • Is a major substrate for the cAMP-dependent protein
kinase in cardiac muscle
• Regulates sarcoplasmic reticulum calcium uptake which
is mediated Ca2+-ATPase by phosphorylation
• Functions in muscle contraction/relaxation mainly in
cardiac muscle [79]
PCSK1 • Is a member of serine endopeptidase family
• Cleaves amino acid residues and modulates precursor
proteins
• Involves in glucose and lipid metabolism [20, 21]
MYBPC1 • Is a member of the myosin-binding protein C family
• Functions as a major myosin thick filament regulatory
proteins [80]
• Plays an important role in muscle contraction by
recruiting muscle-type creatine kinase to myosin
filaments [81]
Down-regulation
IL23R • Associates constitutively with Janus kinase 2 (JAK2),
and also binds to transcription activator STAT3 in a
ligand-dependent manner [82]
GPM6A • Plays a role as a modulator for neurite outgrowth and
spine formation [83]
• Functions as a nerve growth factor-gated Ca2+ channel in
neuronal differentiation [84]
Table 3 Biological functions of the 10 most up- and
down-regulated genes (Continued)
KL • Is a type-I membrane protein that is related to
beta-glucosidases
• Is an important FGF23 signaling cofactor [85]
• Results in chronic renal failure by reduced production [86]
AGMAT • Converts agmatine to putrescine in the pathway of
arginine-agmatine-polyamine pathway
• Functions in embryonic survival, growth, and
development [87]
DKK2 • Antagonize Wnt signaling by binding to LRP5/6 and a
single-transmembrane protein called Kreme [88]
• Has a role in osteoblast differentiation into mineralized
matrices [89]
GABRD • Is a ligand-gated chloride channel
• Functions in neurosteroid modulation [90]
FGB • Is a blood-borne secreting glycoprotein
• Has roles in cell adhesion and spreading,
• Functions as mitogen [91]
PPDPF • Is also known as exocrine differentiation and proliferation
factor (EXDPF)
• Expresses highly in the exocrine cell progenitors and
differentiated cells of the developing pancreas in
zebrafish [92]
ACE • Involves in catalyzing the conversion of angiotensin I into
a physiologically active peptide angiotensin II.
• Plays a key role in the renin-angiotensin system
• Expresses in skeletal muscle and is potent to generate
skeletal muscle atrophy with angiotensin II and AT-1
receptor (AGTR1) functions [23]
CD9 • Is a member of the transmembrane 4 superfamily, also
known as the tetraspanin family
• Is a cell surface glycoprotein
• Functions in differentiation, adhesion, and signal
transduction [93]
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MYBPC1, and MYOZ2 genes compared to unaffected
muscle), suggested fiber type switching from fast- to slow
type fibers. In addition to the 10 most upregulated genes,
expression of MB (10.85 fold) and MYOZ2 (5.90 fold)
were also highly upregulated in PeM compared to BPR
(Additional file 2). Taken together, PeM muscles may con-
tain increased slow fiber compositions compared to BPR.
Regarding upregulation of PLIN1 (perilipin 1) in PeM,
mammalian PLIN1 is known to be expressed in adipose
tissue, but not in skeletal muscle [18]. In this study,
PLIN1 from each bird showed a very low expression
level (range of 10 – 66 raw read counts) in BPR breast
muscle while relatively higher expression (range of
260 – 1,700 raw read counts) was observed in PeM
breast muscles. Possibly, these data indicate that a po-
tentially new pathway related to hormone sensitive
lipase is activated in the large muscle mass of modern
broilers compared to the leaner mass in the unse-
lected foundation BPR line. Additionally, increased
expression of adipose genes showed that PeM muscles
may retain increased mass of adipose tissues, where
the wooden breast myopathy showed increased occur-
rence of irregular adipose tissue throughout the muscle
[19]. Higher expression of NOXO1 (NADPH oxidase or-
ganizer 1) indicates that oxidative stress and scavenging
antioxidants are closely associated with feed efficiency,
which has been reported previously [2, 3, 5]. PCSK1
(proprotein convertase subtilisin/kexin type 1) is not re-
stricted to the expression in muscle tissues, and its func-
tions in glucose and lipid metabolism [20, 21] implies that
PeM muscle has more active cellular pathways for energy
metabolism. Active energy metabolism has been known to
be closely connected to oxidative stress in muscle [22].
In contrast to the 10 most up-regulated genes, expres-
sion of the 10 most down-regulated genes in PeM mus-
cles are not restricted to muscle, but are expressed in
most tissues and organs (Tables 2 and 3). Of the 10 most
down-regulated genes, six genes are classified to mem-
brane bound channels and secreting factors [IL23R, KL,
GPM6A, GABRD (gamma-aminobutyric acid (GABA) A
receptor, delta), FGB (fibrinogen beta chain), PPDPF
(pancreatic progenitor cell differentiation and prolifera-
tion factor) and CD9], indicating that PeM muscles may
retain characteristics of lower amounts of secreting
factors compared to BPR muscles. The expression of
ACE, in combination with angiotensin II and AGTR1
(angiotensin II type 1 receptor), can produce muscle at-
rophy [23], indicating that down-regulation of ACE in
PeM muscle may contribute to muscle hypertrophy
compared to BPR chickens. Davis et al. [7] also observed
elevated ACE in a heritage (Illinois) broiler compared to
modern broiler (Ross) and hypothesized that this would
play a role in lowering protein synthesis and muscle
development in the slower growing Illinois broiler.
Overview of IPA analysis
For more stringent pathway analyses, DE genes in
muscle from PeM and BPR were subjected to biological
functional analyses using Ingenuity Pathway Analysis
(IPA, Qiagen, Valencia, CA) and the analytic settings
were limited to publications on muscle tissue only. The
summary of IPA analysis in diseases, molecular, cellular
and physiological functions for DE genes are presented
in Table 4. The most relevant biological functions in
skeletal muscles comparison between PeM and BPR in-
cluded organismal injury/abnormalities, carbohydrate
metabolism, cellular growth/proliferation, small mol-
ecule biochemistry, abnormal morphology of muscle,
angiogenesis of skeletal muscle, and myogenesis of skel-
etal muscles. Further functional analyses including major
functions of DE genes, canonical pathways, biological
functions, upstream analyses, and molecular networks
that can influence muscle growth and feed efficiency are
discussed below.
Downregulation of mitochondrial function in PeM muscle
A total of 168 differentially expressed mitoproteome genes
were independently analyzed by IPA to characterize func-
tional alterations of mitochondrial energy expenditure and
cellular respiration. As expected, mitochondrial functions
including oxidative phosphorylation, and TCA cycle activ-
ity were downregulated in PeM muscles compared to BPR
muscles (Additional file 3: Figure S1 and Additional file
4). Mitochondrial complex 2, 3, 4, and 5 were downregu-
lated in PeM (with no change in complex 1) and the genes
responsible for oxidative phosphorylation were decreased
in PeM compared to BPR. Likewise, the responsible genes
for TCA cycles were decreased in PeM compared to BPR
(Additional file 4).
Canonical Pathways
IPA analysis generated 380 canonical pathways with DE
genes and most of them were associated with general
signal transduction pathways which are not limited to
muscle growth/mass or feed efficiency. Thus, the two
most relevant pathways for rapid growth and greater
mass of muscle (up-regulated PDGF signaling pathway;
[24, 25]) and feed efficiency (Up-regulation of NFE2L2
mediated oxidative stress pathway; [5, 26]) are discussed
below. Other potentially important canonical pathways
will be discussed in future study.
Up-regulated PDGF signaling pathway
The PDGF signaling pathway appeared to be activated in
PeM compared to BPR chickens. PDGFR α and β sub-
units, and their downstream signal transduction mole-
cules, including JAK, SRC, STAT1 (signal transducer
and activator of transcription 1), STAT3, RAS (ras onco-
gene), PLCγ (phospholipase C, gamma), PKC (protein
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kinase C), cJUN (cellular Jun protooncogene), cFOS
(cellular FBJ murine osteosarcoma viral oncogene
homolog), MEKK1 (MAPK/ERK kinase kinase, a.k.a.
MAP3K1, mitogen-activated protein kinase kinase kin-
ase 1), MKK4 (mitogen activated protein kinase 4, a.k.a.
MAP2K4, mitogen activated protein kinase kinase 4),
and JNK1 were upregulated or predicted to be activated
(Fig. 3). Since skeletal muscle cell itself does not prolifer-
ate and PDGF is known to stimulate the proliferation of
muscle satellite cells [24, 25], increased activity of PDGF
signaling pathways to STAT1/STAT3 complex [27] and
to cJUN/cFOS complex [28] may influence satellite cell
formation and its proliferation, resulting in greater
muscle cell growth in PeM chickens compared with
BPR. Additionally, upregulation of PDGF signaling
pathways in PeM muscle may represent a possible
subclinical condition of monocyte infiltration of the
regenerating muscle tissues, which has been observed
as part of wooden breast myopathy in modern com-
mercial broilers [17, 19].
Up-regulation of NFE2L2 mediated oxidative stress pathway
Recently, Zhou et al. [5], reported that with commercial
broiler chickens, NFE2L2 (nuclear factor, erythroid 2-
like 2; also known as NRF2; Fig. 4) mediated oxidative
stress pathway was predicted to be activated in breast
muscles in PeM compared to low feed efficiency muscle
in commercial broilers. In addition, our recent proteo-
mics results showed that NFE2L2 was also predicted to
be activated in the high feed efficiency pedigree male
[26]. NFE2L2 as a key transcription factor induces a
number of antioxidant genes in response to oxidative
stress as well as tissue injury and inflammation [29]. In
the present study, NFE2L2 was predicted to be activated
in PeM compared to BPR based on the increased expres-
sion of downstream targets including TRXR1 (thioredoxin
reductase 1 or TXNRD1 in Additional file 2), SOD
(superoxide reductase or SOD3 in Additional file 2), CAT
(catalase), HO-1 (heme oxygenase 1 or HMOX1 in
Additional file 2) and MAF (v-maf avian musculoaponeu-
rotic fibrosarcoma oncogene homolog or MAFA/MAFF
in Additional file 2) (Fig. 4). However, the expression of
other molecules that respond to NFE2L2 were variable
(Table 5). In addition, many other genes [CAT, CCL5
(chemokine C-C motif ligand 5), DUSP1 (dual specificity
phosphatase 1), FOS, JUN, MGST1 (microsomal glutathi-
one S-transferase 1), PRDX4 (peroxiredoxin 4), SOD3,
STAT3, VCAM1 (vascular cell adhesion molecule 1), and
XDH (xanthine dehydrogenase)], along with several anti-
oxidant genes associated with oxidative stress, were upreg-
ulated in PeM muscle compared to BPR (Table 6). Earlier
biochemical studies for mitochondrial functions and oxi-
dative respirations with breast muscle tissues of high- and
low feed efficiency chickens reported lowered ROS levels
in high feed efficiency chickens [10, 22], indicating high
feed efficiency muscles (or rapidly growing muscles) retain
more efficient scavenging mechanisms to reduce ROS
levels compared to low feed efficiency muscle. Thus, ra-
ther than the possibilities that higher levels of oxidative
stress may play a role for PeM, the fact that maintaining
low ROS levels caused by higher antioxidant functions is
necessary for rapid growth would be a better explanation
for the biological functions of the DE genes. Taken to-
gether, NFE2L2 mediated antioxidant/detoxifying pathway
appears to be more active in muscle of modern PeM
broilers compared to BPR chickens.
Upstream regulators and network analyses
Upstream regulators and gene network analyses, which
represent the intermolecular connections among inter-
acting genes based on functional knowledge inputs, were
performed on the DE genes using the IPA program. IPA
Table 4 Top diseases, molecular, cellular, and physiological functions for differentially expressed genes in PeM compared to BPR
Functions P-Value Molecules
Diseases and disorders
Organismal Injury and Abnormalities 3.22E-02 CXCL1, EGR1, IL13RA2, NOX4
Molecular and Cellular Functions
Carbohydrate Metabolism 2.19E-02 ACACB, CRAT, FABP3, GFPT1, NHLRC1, NRG1, NUAK1, PKNOX1, PPARD,
PPARG, PRKAA1, PRKAB2, PRKCB, PRKCD, UCP3, UGP2
Cellular Growth and Proliferation 2.18E-02 ATM, DCN, MSTN, HEY1, MYC, MYF5, PITX2, PRNP
Small Molecule Biochemistry 2.19E-02 CRAT, NRG1, PKNOX1, PPARG, PRKAA1, PRKCD, UCP3
Physiological System Development and Function
Skeletal and Muscular System Development and
Function
- Abnormal Morphology of muscle
1.89E-02 CALCRL, CHRNG, COL6A1, CRK, CXCL12, DES, DLG1, ELN, ESR2, FBN1, FN1, FST,
HEY1, HLX, INPP5days, KLF2, LMO7, LOX, LPL, MB, MEOX2, MGP, MMP2, MSTN,
MTM1, MYF5, NGFR, PITX2, PPARGC1A, SRPK3
- Angiogenesis of Skeletal Muscle 9.22E-03 CXCL12, MYH9, PPARGC1A, PPARGC1B, VEGFA
Embryonic Development
- Myogenesis of Skeletal Muscle
1.25E-02 CAPN3, CSRP3, CXCL12, ELN, GPCPD1, HLX, MEOX2, MSC, MSTN, MYF5, MYH9,
PITX2, PPARGC1A, PPARGC1B, RGS2, SIX1, SRPK3, SVIL, UTRN, VEGFA26
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analyses selected 11 potentially important upstream reg-
ulators (p-value <0.05) and 9 meaningful molecular net-
works (data not shown). Interestingly most networks
were centered with the upstream regulators. The up-
stream regulators centered in the molecular networks,
that are possibly important for muscle growth and feed
efficiency are presented below and gene information
including full gene name and fold change values for
focus molecules in each network are listed in Additional
file 5.
MSTN
The first molecule of interest was MSTN (myostatin), a
member of TGF-β family, which is an important nega-
tive regulator of skeletal muscle growth [30]. MSTN
expression was higher in PeM muscle compared to BPR
muscle (Additional file 2). Although the DE of a few
downstream target molecules [e.g. DES (desmin) and
IGF2 (insulin like growth factor 2)] was indicated as be-
ing inconsistent with previous reports [31, 32], the
downstream molecules of MSTN including increased ex-
pression of FN1 (fibronectin 1), PID1 (phosphotyrosine
interaction domain containing 1), SERPINH1 [serpin
peptidase inhibitor, clade H (heat shock protein 47),
member 1, (collagen binding protein 1)], CTSV (cathep-
sin V) and decreased expression of PPARGC1A [peroxi-
some proliferator-activated receptor gamma, coactivator
1 alpha; PGC1α] [31–34] indicated that the functional
MSTN activity or expression was enhanced in PeM
compared to BPR (Fig. 5). Since PeM chickens grow
much faster than BPR, MSTN functions in PeM were
expected to be less active than BPR, but the result was
opposite. The qPCR of MSTN was consistent with
RNAseq result (Table 1) and no single nucleotide poly-
morphisms (SNP) altering an amino acid residue were
found in MSTN cDNA sequences in both PeM and BPR
Fig. 3 PDGF signaling pathway. Green, red, orange and blue represent down-regulation, up-regulation, predicted up-regulation and predicted
down-regulation, respectively. Symbols for each molecule are presented according to molecular functions and type of interactions. Prediction leg-
ends showed color schemes of shapes and connecting lines
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chickens (data not shown). According to a recent
RNAseq report comparing a modern pedigree broiler
(ROSS) muscle and to that in heritage chicken (Illinois)
muscles, MSTN expression was very similar in both
chicken lines and showed relatively high expression
levels (~30 RPKMs) in both lines, though slightly higher
expression was observed in pedigree broiler muscles
than heritage chicken muscles [7]. Similarly, the MSTN
expression in this study showed relatively abundant ex-
pression levels in both BPR (range of 380 – 1000 raw
read counts) and in PeM (range of 1000 – 2100 raw read
counts) breast muscles (data not shown). Thus, assum-
ing no mutations were involved in the MSTN gene in
both lines, high expression levels of MSTN could be
hypothesized to prevent extreme muscle growth in both
PeM and BPR. The regulatory factors that modulate the
function of TGF-β family including MSTN, secreted
protein follistatin (FST), together with its associated pro-
teins (follistatin like 1, FSTL1 and follistatin like 3,
FSTL3) are known as potent antagonists of myostatin
that take advantage of its ability to hinder access to sig-
naling receptors on skeletal muscle [35, 36]. The DE
genes in this study showed that FST and FSTL1 expres-
sion were upregulated by 3.86 and 1.73 fold changes, re-
spectively, in PeM compared with BPR muscles
(Additional file 2), while FSTL3 expression was not
detected. Function of abundantly expressed MSTN
appears to be attenuated by the autocrine or paracrine
effects of upregulated FST and its associated FSTL1 in
PeM muscles compared to BPR muscles, resulting in the
greater muscle growth in PeM chickens. Therefore, the
MSTN functions on the muscle growth may be mediated
Fig. 4 NRF2 mediated oxidative stress pathway. Molecular interaction, symbols, and color schemes are the same as the description in Fig. 3.
White symbols indicate neighboring genes that are functionally associated, but not included in the DE gene list
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by the interactions between MSTN and its regulatory fac-
tors (e.g. FST and FSTLs), not by the differential expression
of MSTN alone. The functional roles of MSTN, its down-
stream effectors, and FST regulation in PeM compared
with BPR need to be investigated more in future studies.
PRKAG3
The regulations centered with PRKAG3 (protein kinase,
AMP-activated, gamma 3 non-catalytic subunit) were
closely associated with functions in organismal injury/
abnormalities, and cellular assembly/organization (Fig. 6).
Table 5 DE genes in NFE2L2 mediated oxidative stress
Symbol Entrez gene name Fold change p-value Location Type (s)
ATM ATM serine/threonine kinase −1.31 3.95E-02 Nucleus kinase
CAT catalase 1.67 7.26E-05 Cytoplasm enzyme
DNAJB5 DnaJ (Hsp40) homolog, subfamily B, member 5 1.56 1.61E-02 Cytoplasm other
DNAJB6 DnaJ (Hsp40) homolog, subfamily B, member 6 1.30 5.86E-03 Nucleus transcription regulator
DNAJB9 DnaJ (Hsp40) homolog, subfamily B, member 9 −1.45 1.94E-03 Nucleus other
DNAJC15 DnaJ (Hsp40) homolog, subfamily C, member 15 −1.39 2.04E-02 Cytoplasm other
DNAJC21 DnaJ (Hsp40) homolog, subfamily C, member 21 −1.97 3.50E-05 Other other
EIF2AK3 eukaryotic translation initiation factor 2-alpha kinase 3 1.39 1.03E-02 Cytoplasm kinase
FOS FBJ murine osteosarcoma viral oncogene homolog 4.66 1.06E-02 Nucleus transcription regulator
HMOX1 heme oxygenase 1 2.53 7.47E-04 Cytoplasm enzyme
HRAS Harvey rat sarcoma viral oncogene homolog 1.43 1.51E-03 Plasma Membrane enzyme
JUN jun proto-oncogene 2.45 2.23E-03 Nucleus transcription regulator
MAP2K3 mitogen-activated protein kinase kinase 3 1.33 1.13E-02 Cytoplasm kinase
MAP2K6 mitogen-activated protein kinase kinase 6 −1.85 1.31E-02 Cytoplasm kinase
MGST1 microsomal glutathione S-transferase 1 1.36 3.58E-02 Cytoplasm enzyme
MRAS muscle RAS oncogene homolog 1.53 4.77E-02 Plasma Membrane enzyme
PIK3CA phosphatidylinositol-4,5-bisphosphate 3-kinase,
catalytic subunit alpha
−1.34 1.15E-02 Cytoplasm kinase
PIK3R1 phosphoinositide-3-kinase, regulatory subunit 1 (alpha) −2.66 1.05E-03 Cytoplasm kinase
PRKCB protein kinase C, beta 2.28 2.15E-03 Cytoplasm kinase
PRKCD protein kinase C, delta 1.41 2.50E-02 Cytoplasm kinase
PRKCH protein kinase C, eta −2.95 7.23E-04 Cytoplasm kinase
SOD3 superoxide dismutase 3, extracellular 2.51 1.48E-02 Extracellular Space enzyme
TXNRD1 thioredoxin reductase 1 1.74 7.60E-04 Cytoplasm enzyme
Table 6 DE genes in oxidative stress pathway
Symbol Entrez gene name Fold change p-value Location Type (s)
CAT catalase 1.67 7.26E-05 Cytoplasm enzyme
CCL5 chemokine (C-C motif) ligand 5 4.47 3.90E-04 Extracellular Space cytokine
DUSP1 dual specificity phosphatase 1 2.73 4.81E-03 Nucleus phosphatase
FOS FBJ murine osteosarcoma viral oncogene homolog 4.66 1.06E-02 Nucleus transcription regulator
JUN jun proto-oncogene 2.45 2.23E-03 Nucleus transcription regulator
MGST1 microsomal glutathione S-transferase 1 1.36 3.58E-02 Cytoplasm enzyme
PRDX4 peroxiredoxin 4 1.40 1.35E-02 Cytoplasm enzyme
SOD3 superoxide dismutase 3, extracellular 2.51 1.48E-02 Extracellular Space enzyme
STAT3 signal transducer and activator of transcription 3 1.30 7.34E-04 Nucleus transcription regulator
VCAM1 vascular cell adhesion molecule 1 1.50 2.49E-02 Plasma Membrane transmembrane receptor
XDH xanthine dehydrogenase 3.86 1.78E-04 Cytoplasm enzyme
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Fig. 5 DE genes regulated by MSTN. Molecular interaction, symbols, and color schemes are the same as the description in Fig. 3
Fig. 6 DE genes regulated by PRKAG3. Molecular interaction, symbols, and color schemes are the same as the description in Fig. 3
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Although there was no expression difference observed
between PeM and BPR, mRNA sequence analysis of
PRKAG3 in BPR muscle revealed an allele specific ex-
pression at nucleotide position (c.943G > A) that induced
a nonsynonymous amino acid change (p. V315M) in 5
out of 6 BPR chickens; however, this was not observed
in PeM sequence results (data not shown). Three and
two BPR samples showed 50% (heterozygous GA geno-
type) and 100% mutations (homozygous AA genotype),
respectively, for PRKAG3. Therefore, DE genes associ-
ated with PRKAG3 appeared to be caused by the differ-
ential protein/kinase function. Expression for TPPP3
(tubulin polymerization-promoting protein family mem-
ber 3), ATP1B1 (ATPase, Na+/K+ transporting, beta 1
polypeptide), BTG2 (BTG family, member 2), KDM2B
(lysine-specific demethylase 2B), RGCC (regulator of
cell cycle), KLF2 (Kruppel-like factor 2), VIMP (VCP-
interacting membrane protein), CD93 (CD93 molecule),
SORD (sorbitol dehydrogenase), LMCD1 (LIM and
cysteine-rich domains 1), ITIH5 (inter-alpha-trypsin in-
hibitor heavy chain family, member 5), and CTNNA1
[catenin (cadherin-associated protein), alpha 1, 102 kDa]
were increased in PeM compared to BPR, while expres-
sion of SLC7A2 [solute carrier family 7 (cationic amino
acid transporter, y + system), member 2], ELL2 (elongation
factor, RNA polymerase II, 2), NRIP1 (nuclear receptor
interacting protein 1) and UGP2 (UDP-glucose pyrophos-
phorylase 2) were decreased by PRKAG3 in PeM. All of
these downstream molecules of PRKAG3 are involved in
either a) glucose metabolism (SORD [37], UGP2 [38],
VIMP [39]), b) cytoskeletal formation (TPPP3 [40], CD93
[41], CTNNA1 [42]), c) cell cycle regulation (BTG2 [43],
CD93 [41], RGCC [44]), d) transcription (ELL2 [45], KLF2
[46], LMCD1 [47]), e) transporters in cell/mitochondrial
membranes (ATP1B1 [48], SLC7A2 [49]), f ) hormone
dependent nuclear receptor (NRIP1 [50]), g) ubiquitina-
tion (KDM2B [51], BTG2 [43]), or h) inflammatory re-
sponse (VIMP [39]). The PRKAG3 associated interactions
were derived from a list of DE genes identified by micro-
array assay that was performed with skeletal muscle tis-
sues of PRKAG3 transgenic mice including missense
point mutation and knock-out genotypes [52]. PRKAG3 is
the muscle-specific predominant γ isoform of adenosine
monophosphate (AMP)-activated protein kinase (AMPK)
and has been shown to play an important role in glucose
uptake, glycogen synthesis, and fat oxidation in white
skeletal muscle (fast twitch fiber) found in pig and mouse
models carrying a mutation of the gene [53–56]. Differen-
tial expression of various downstream effector molecules
of PRKAG3 suggests that muscle specific AMPK pathway
may play important roles in metabolism of glucose and
lipids with additional cellular functions in the muscle
growth, regeneration of the degenerated muscle tissues,
differential muscle fiber composition, and feed efficiency
phenotypic expression in chicken. This concept is sup-
ported by the fact that the most relevant molecular and
cellular function identified by IPA analysis was carbohy-
drate metabolism that involved with 16 molecules
(Table 4). AMPK has been known to play important roles
to regulate feed efficiency related to mitochondrial func-
tions in chicken muscle [2–4]. AMPK functions in
monitoring cell energy status and adjusts ATP pro-
duction to meet cellular needs. The AMPK is stimu-
lated by increased AMP to ATP ratio and enhances
energy production by stimulating mitochondrial
biogenesis.
LIPE
The regulation of LIPE (lipase E, hormone sensitive),
which is predicted to be activated in PeM compared to
BPR, is involved in cell morphology, connective tissue
development/function, and tissue morphology (Fig. 7).
LIPE associated regulation was derived from an earlier
report which identified DE genes and proteins in soleus
muscle tissues of LIPE null mice compared with wild-
type littermates using microarray and two dimensional
gel electrophoresis based mass-spectrometry proteomics
assays [57]. Expressions for RRAD (Ras-related associ-
ated with diabetes), ST8SIA4 (ST8 alpha-N-acetyl-neur-
aminide alpha-2,8-sialyltransferase 4), CDO1 (cysteine
dioxygenase type 1), COL1A2 (collagen, type I, alpha 2),
YWHAG (tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, gamma), CSRP3 [cyst-
eine and glycine-rich protein 3 (cardiac LIM protein)],
MEOX2 (mesenchyme homeobox 2), BCL6 (B-cell CLL/
lymphoma 6), and ANKRD1 [ankyrin repeat domain 1
(cardiac muscle)] were up-regulated in PeM compared to
BPR, while expression of RAMP1 [receptor (G protein-
coupled) activity modifying protein 1], AQP1 (aquaporin
4), PHKG1 [phosphorylase kinase, gamma 1 (muscle)],
ARNTL (aryl hydrocarbon receptor nuclear translocator-
like) and SUCLA2 (succinate-CoA ligase, ADP-forming,
beta subunit) were downregulated. Hormone-sensitive lip-
ase E is a key enzyme in fatty acid mobilization in adipo-
cytes and muscle LIPE has been shown to be activated by
adrenaline-mediated protein kinase A phosphorylation in
mammals [58] as well as by a contraction-induced mech-
anism, which is independent of protein kinase A [59].
Although LIPE may have critical functions in mammalian
muscle, to date, the avian LIPE gene has not been identi-
fied in the genome, transcriptome or proteome. Previ-
ously, only a partial 86 kDa protein for the LIPE enzyme
was purified from chicken adipose tissue and lipase activ-
ity was confirmed [60]. Since mammalian LIPE genes
showed high sequence similarity, we tried to identify
muscle LIPE gene expression in chicken based on mam-
malian LIPE gene information but this was unfortunately
not successful (data not shown). Therefore, detailed
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functional discussion on avian muscle LIPE will have to
wait until the avian LIPE gene is identified.
Androgen receptor (AR)
A steroid hormone receptor, AR (androgen receptor)
was predicted to be inhibited in PeM muscle (Fig. 8). AR
expression observed from the re-analysis of muscle tran-
scriptome on Ross and Illinois chickens showed a signifi-
cant downregulation (−2.0 fold, p-value = 0.0003) in Ross
chicken muscle at 21 day post hatch compared to Illinois
chicken [7]. These results support the inhibition of AR
functions in modern broiler muscle tissues compared to
unselected chicken breeds. AR is a ligand (androgen)-in-
ducible transcription factor that binds to specific DNA
sequences called androgen response elements (AREs) via
its DNA-binding domain (DBD) and recruits coactiva-
tors that facilitate the transcription of target genes [61].
AR and androgen activate muscle-specific genes
encoding structural proteins and myogenic factors [62].
Androgens and AR may activate the estrogen receptor
after aromatization [63] and play a role in anabolic
action in skeletal muscle through crosstalk with
other signaling molecules [64]. Although MSTN and
NMRK2 (nicotinamide riboside kinase 2), which are
known to be transcriptionally activated by AR, were
not consistent with earlier findings [65, 66], expression
of IGF2, CSRP3 [cysteine and glycine-rich protein 3
(cardiac LIM protein)], ATP2A2 (ATPase, Ca++ trans-
porting, cardiac muscle, slow twitch 2), and TNNT2
[troponin T type 2 (cardiac)] were upregulated in AR
receptor knock-out mice [65, 66], suggesting that
increased expression of these genes in PeM muscle may
be caused by the inhibition of AR functions compared to
BPR. Predicted inhibition of AR indicated that steroid
receptor- mediated transcriptions were down-regulated
in modern broiler PeM compared to progenitor BPR
muscles.
Summary and conclusion
In this study, we have demonstrated DE genes in breast
muscle of modern PeM (rapid growth, high feed effi-
ciency) broiler breeder compared to BPR unselected
foundational breed (slow growth, low feed efficacy).
Thousands of DE genes involved a variety of cellular and
physiological functions in muscle growth and energy
metabolism. In addition, many differences reflecting
differential muscle fiber composition were characterized
in the two chicken breeds. The highly upregulated genes
in PeM may represent phenotypes of subclinical myop-
athy commonly observed in the commercial broiler
breast tissue, that can lead to muscle hardening, named
as woody breast. Importantly, this study suggests that
the fiber composition of avian breast muscle is not
consistent with mammalian white muscle in regard to
Fig. 7 DE genes regulated by LIPE. Molecular interaction, symbols, and color schemes are the same as the description in Fig. 3
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differential mitochondrial content and function. The
results of this study provide insights into the genetic
alterations accumulated in modern broiler breeder
line during selective breeding conducted over several
decades.
Additional files
Additional file 1: Primers used for qRT-PCR. The first column indicates
primer names and the second column shows sequences for the forward
and reverse primers. (XLSX 9 kb)
Additional file 2: List of entire 2464 DE genes in the comparison of
PeM and BPR. (XLSX 141 kb)
Additional file 3: Figure S1. The canonical pathway of oxidative
phosphorylation. The differentially expressed genes in breast muscle
associated with the electron transport chain on (Complex I, II, III, IV, and
V) that were downregulated (outlined in green) in the PeM. Pumping of
hydrogen ions (H+) creates a proton motive force between the inner
(IMM) and outer (OMM) mitochondrial membranes that is used to drive
ATP synthesis. (PPTX 254 kb)
Additional file 4: List of DE genes in TCA cycles and oxidative
phosphorylation. Gene symbols, full gene name and fold change values
were displayed. (XLSX 11 kb)
Additional file 5: List of focus molecules in gene networks and
upstream analysis. Gene symbols, full gene name and fold change values
were displayed for the illustrations of network and upstream analyses.
(XLSX 14 kb)
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RPKM: Reads per kilobase per million; RPM: Reads per million; RRAD: Ras-
related associated with diabetes; SCN5A: Sodium channel voltage gated
type V alpha subunit; SERPINH1: Serpin peptidase inhibitor clade H heat
shock protein 47 member 1; SLC38A4: Solute carrier family 38 member
4; SLC7A2: Solute carrier family 7 member 2; SNP: Single nucleotide
polymorphisms; SOD3: Superoxide reductase 3; SORD: Sorbitol
dehydrogenase; SRC: SRC protooncogene; ST8SIA4: ST8 alpha-N-acetyl-
neuraminide alpha-2,8-sialyltransferase 4; STAT1: Signal transducer and
activator of transcription 1; STAT3: Signal transducer and activator of
transcription 3; SUCLA2: Succinate-CoA ligase ADP-forming beta subunit;
TCA: tricarboxylic acid; TGF-β: Transforming growth factor beta;
TNC: Tenascin C; TNNI1: Troponin I 1; TNNT2: Troponin T type 2 cardiac;
TPM3: Tropomyosin 3; TPPP3: Tubulin polymerization-promoting protein
family member 3; TRXR1 or TXNRD1: Thioredoxin reductase 1;
UGP2: UDP-glucose pyrophosphorylase 2; VCAM1: Vascular cell adhesion
molecule 1; VIMP: VCP-interacting membrane protein; XDH: Xanthine
dehydrogenase; YWHAG: Tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein gamma
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